REFERENCES
- Cetin I, Berti C, Mando C, et al. Placental iron transport and maternal absorption. Ann Nutr Metab 2011;59(1):55–58.
- Gomme PT, McCann KB. Transferrin: structure, function and potential therapeutic actions. Drug Discov Today 2005;10(4):267–273.
- Kamp G, Mulder K, Kuiper M, et al. Changed transferrin sialylation in Parkinson's disease. Clin Chim Acta 1995;235(2):159–167.
- Cywlik B, Chrostek L, Szmitkowski M. New methods for the determination of transferrin isoforms in the diagnostics of alcohol abuse. Postepy Hig Med Dosw 2006;60:101–112.
- Wu Y, Sakamoto H, Kanenishi K, et al. Transferrin microheterogeneity in pregnancies with preeclampsia. Clin Chim Acta 2003;332(1–2):103–110.
- Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991;37(12):2029–2037.
- Niehues R, Hasilik M, Alton G et al. Carbohydrate-deficient glycoprotein syndrome type Ib: phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 1998;101(7):1414–1420.
- De Jong G, Feelders R, Noort WL, et al. Transferrin microheterogeneity as a probe in normal and disease states. Glycoconj J 1995;12(3):219–226.
- Feelders RA, Vreugdenhil G, Jong G, et al. Transferrin microheterogeneity in rheumatoid arthritis. Rheumatol Int 1992;12(5):195–199.
- Mandruzzato G, Antsaklis A, Botet F, et al. Intrauterine restriction (IUGR). J Perinat Med 2008;36(4):277–281.
- Rosenberg A. The IUGR newborn. Semin Perinatol 2008;32:219–224.
- Roberts I, Stanworth S, Murray NA. Thrombocytopenia in the neonate. Blood Rev 2008;22:173–186.
- Jasińska E, Wasiluk A. Intrauterine fetal growth restriction (IUGR) as a clinical problem. Perinat Neonat Ginekol 2010;4(3):255–261.
- Aliyu MH, Lynch O, Wilson RE, et al. Association between tobacco use in pregnancy and placenta-associated syndromes: a popular-based study. Arch Gynecol Obstet 2011;283(4):729–734.
- Rogers JM. Tobacco and pregnancy. Reprod Toxicol 2009;28(2):152–160.
- Van Rensburg SJ, Berman P, Potocnik F, et al. 5- and 6-Glycosylation of transferrin in patients with Alzheimer's disease. Metab Brain Dis 2004;19(1–2):89–96.
- Hunt RC, Riegler R, Davis AA. Changes in glycosylation alter the affinity of the human transferrin receptor for its ligand. J Biol Chem 1989;2655(16):9643–9648.
- Verrijt CEH, Kroos MJ, van Noort WL, et al. Binding of human isotransferrin variants to microvillous and basal membrane vesicles from human term placenta. Placenta 1997;18(1):71–77.
- Lanz C, Kuhn M, Deiss V, et al. Improved capillary electrophoresis method for the determination of carbohydrate-deficient transferrin in patient sera. Electrophoresis 2004;25(14):2309–2318.
- Dejmek J, Solansky I, Podrazilova K, et al. The exposure of nonsmoking and smoking mothers to environmental tobacco smoke during different gestational phase and fetal growth. Environ Health Prospect 2002;110(6):601–606.
- Rao R, Georgieff M. Iron in fetal and neonatal nutrition. Semin Fetal Neonatal Med 2007;12(1):54–63.
- Bizoń A, Milnerowicz-Nabzdyk E, Zalewska M, et al. Changes in pro/antioxidant balance in smoking and non-smoking pregnant women with intrauterine growth restriction. Reprod Toxicol 2011;32(3):360–367.
- Bulterys M, Greenland S, Kraus J. Chronic fetal hypoxia and sudden infant death syndrome: interaction between maternal smoking and low hematocrit during pregnancy. Pediatrics 1990;86(4):535–540.
- Sifakis S, Pharmakides G. Anemia in pregnancy. Ann N Y Acad Sci 2000;900(1):125–136.
- Kenan N, Larsson A, Axelsson O, et al. Changes in transferrin glycosylation during pregnancy may lead to false-positive carbohydrate-deficient transferrin (CDT) results in testing for riskful alcohol consumption. Clin Chim Acta 2011;412(1–2):129–133.
- Scholl TO. Maternal iron status: relation to fetal growth, length of gestation, and iron endowment of the neonate. Nutr Rev 2011;69(1):S23–S29.
- Sillanaukee P, Alho H, Strid N, et al. Effect of hormone balance on carbohydrate-deficient transferrin and gamma-glutamyltransferase in female social drinkers. Alcohol Clin Exp Res 2000;24(10):1505–1509.
- Das SK, Vasudevan DM. Should we use carbohydrate deficient transferrin as a marker for alcohol abusers? Indian J Clin Biochem 2004;19(2):36–44.
- Feo TM, Fargion S, Duca L, et al. Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron. Hepatology 1999;29(3):658–663.
- Cylwik B, Chrostek L, Szmitkowski M, et al. Carbohydrate-deficient isoforms of transferrin (%CDT) and sialic acid (SA) in iron-deficiency anemia. Clin Lab Haem 2005;27(5):297–301.
- Bergström JP, Helander A. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin Chim Acta 2008;388(1–2):59–67.